About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
The Diabetes and Metabolism Research Group is search is lead by Dr. Rafael Simó (Hirsch index:54), Head of the Endocrinology Department, Professor of Medicine & Endocrinology at UAB and current President of the European Association for the Study of Diabetes-Eye Complications. The group consists of 7 senior clinical investigators, 4 basic post-doctoral researchers, 4 pre-doc researchers, 3 laboratory technicians and one coordinator of clinical assays.
The group belongs to “CIBER” of Diabetes and Associated Metabolic Diseases (CIBERDEM. ISCIII) and has been recognized as consolidated group by the Generalitat de Catalunya (AQU/AGAUR).
Since 2014 this group has been qualified as outstanding in the evaluations performed by the ANEP, CIBERDEM and the external Scientific Advisory Board of VHIR.
The main lines of research are:
IP: Rafael Simó Canonge Collaborators: - Funding agency: Fundació "La Caixa" Funding: 99946 Reference: SR20-00730 Duration: 01/02/2021 - 30/09/2024
IP: Rafael Simó Canonge Collaborators: Marc Rivas Agudo, Cristina Hernández Pascual, José García Arumí Funding agency: Instituto de Salud Carlos III Funding: 573650 Reference: ICI20/00129 Duration: 01/01/2021 - 31/10/2026
IP: Inmaculada Fuentes Camps Collaborators: Gemma Vona Giralt, Antonio Moreno Galdó, Rafael Simó Canonge, Núria Pérez Picazo, Tamara Del Rio Higueras, Ariadna Martín Balcells, Olga Sánchez- Maroto Carrizo, Angelica Valderrama Rodríguez, Joan Genescà Ferrer, Paula Isabel Roldan Caballero Funding agency: Instituto de Salud Carlos III Funding: 315150 Reference: PT20/00078 Duration: 01/01/2021 - 31/12/2024
IP: Maria Jose Soler Romeo Collaborators: Mario Alonso Narvaez Barros, Pamela Dominguez Baez, Sheila Bermejo Garcia, Alejandra Planas Vilaseca, Concepció Jacobs Cachá, Juan Carlos León Román Funding agency: Instituto de Salud Carlos III Funding: 122210 Reference: PI21/01292 Duration: 01/01/2022 - 30/06/2026
PMID: 38000766 Journal: JOURNAL OF BIOMEDICAL INFORMATICS Year: 2023 Reference: J Biomed Inform. 2023 Nov 22:104553. doi: 10.1016/j.jbi.2023.104553. Impact factor: Publication type: Paper in international publication Authors: Amasi-Hartoonian, Nare; Ammour, Nadir; Begum, Amina; Blanco, Albert; Brown, Mollie; Comas, Immaculada; Conesa, Laura; Couvert, Camille; Diaz-Troyano, Noelia; Didden, Eva-Maria et al. DOI: 10.1016/j.jbi.2023.104553
PMID: 38017616 Journal: DIABETIC MEDICINE Year: 2023 Reference: Diabet Med. 2023 Nov 28:e15259. doi: 10.1111/dme.15259. Impact factor: Publication type: Paper in international publication Authors: Aanstoot, Henk-Jan; Aguilera, Antonio; Benard, Angele Helene Marie; Benito, Rafael; de-Mendoza, Carmen; Del Pozo, Carmen Hurtado; Delbecque, Laure; Due-Christensen, Mette; Eeg-Olofsson, Katarina; Eiros, Jose Maria et al. DOI: 10.1111/dme.15259
PMID: 38039432 Journal: JCO Precision Oncology Year: 2023 Reference: JCO Precis Oncol. 2023 Sep;7:e2300338. doi: 10.1200/PO.23.00338. Impact factor: Publication type: Paper in international publication Authors: Aas, Turid; Aase, Hildegunn S; Alvarez-Escola, Cristina; Araujo-Castro, Marta; Aulinas, Anna; Bernabeu, Ignacio; Biagetti, Betina; Blanco, Concepcion; Blix, Egil S; Calatayud, Maria et al. DOI: 10.1200/PO.23.00338
PMID: 38033321 Journal: EUROPEAN JOURNAL OF ENDOCRINOLOGY Year: 2023 Reference: Eur J Endocrinol. 2023 Nov 30:lvad160. doi: 10.1093/ejendo/lvad160. Impact factor: Publication type: Paper in international publication Authors: Aanstoot, Henk-Jan; Alonso, T; Barbas, C; Benard, Angele Helene Marie; Benavent, M; Capdevila, J; Carretero-Puche, C; Castellano, D; Custodio, Ana; Del Pozo, Carmen Hurtado et al. DOI: 10.1093/ejendo/lvad160
PMID: 33357713 Journal: Endocrinologia, diabetes y nutricion Year: 2021 Reference: Endocrinol Diabetes Nutr. 2021 Jan;68(1):1-2. doi: 10.1016/j.endinu.2020.11.001. Impact factor: 0 Publication type: Editorial in national publication Authors: Biagetti, Betina, Simo, Rafael et al. DOI: 10.1016/j.endinu.2020.11.001
The European project, in which Vall d'Hebron participates, will favor personalized diagnosis and innovative therapeutic strategies in patients with the disease.
This investment from EIT Health in the project will enable D-Sight to progress in the clinical development of its groundbreaking treatment for the early stages of diabetic retinopathy.
This initiative of the ”la Caixa” Foundation offers the selected entrepreneurial scientists financial support and support through individual mentoring and training.
